Global DPCR Market 2021-2025 The analyst has been monitoring the dPCR market and it is poised to grow by $ 695. 07 mn during 2021-2025, progressing at a CAGR of 25. 17% during the forecast period.
New York, Oct. 04, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global dPCR Market 2021-2025" - https://www.reportlinker.com/p04796789/?utm_source=GNW
Our report on the dPCR market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by rising focus on disease diagnosis and drug discovery and development, rapid technological advances, and demand for high throughput technology. In addition, rising focus on disease diagnosis and drug discovery and development is anticipated to boost the growth of the market as well.
The dPCR market analysis includes the product segment and geographic landscape.
The dPCR market is segmented as below:
By Geographical Landscape
• North America
• South America
This study identifies the increasing popularity of dPCR as one of the prime reasons driving the dPCR market growth during the next few years. Also, rising prominence of PCR solutions in the biomedical sector and migration of manufacturing and sales facilities to APAC will lead to sizable demand in the market.
The analyst presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on dPCR market covers the following areas:
• dPCR market sizing
• dPCR market forecast
• dPCR market industry analysis
This robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading dPCR market vendors that include Avance Biosciences Inc., Becton Dickinson and Co., Bio-Rad Laboratories, Inc, Fluidigm Corp., JN Medsys Pte. Ltd., Merck and Co. Inc., QIAGEN NV, Stilla Technologies Inc., Sysmex Asia Pacific Pte Ltd., and Thermo Fisher Scientific Inc. Also, the dPCR market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The analyst presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Read the full report: https://www.reportlinker.com/p04796789/?utm_source=GNW
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
CONTACT: Clare: email@example.com US: (339)-368-6001 Intl: +1 339-368-6001